NCT04455620 - BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 26, 2021

Primary Completion Date

May 28, 2024

Study Completion Date

May 28, 2024

Conditions

Solid Tumor

Interventions

BIOLOGICAL

BNT151

intravenous (IV)

Trial Locations (6)

START Madrid - HM CIOCC, Madrid

Sarah Cannon Research Institute at Tennessee Oncology, Nashville

University of Texas MD Anderson Cancer Center, Houston

NEXT Oncology, San Antonio

Yale Cancer Center, New Haven

Vall d´Hebron Institute of Oncology (VHIO), Barcelona